臨床検査49巻13号

2005年12月発行

今月の主題 メタボリックシンドローム メタボリックシンドロームの臨床検査

インスリン抵抗性

著者： 荻野淳¹ 齋藤康¹

所属機関： ¹千葉大学大学院医学研究院細胞治療学

ページ範囲：P.1707 - P.1712

〔SUMMARY〕　メタボリックシンドロームはインスリン抵抗性を基盤とした症候群と考えられている．インスリン抵抗性の評価には空腹時インスリン値，HOMA-Rなどの比較的簡便な方法から，グルコースクランプ法，SSPG法，ミニマルモデル法，インスリン負荷試験など多くの方法があり，それぞれの検査の特徴を十分理解したうえで行うことが重要である．〔臨床検査　49：1707-1712，2005〕

参考文献

１) Reaven GM：Banting lecture 1988. Role of insulin resistance in human disease. Diabetes　37：1595-1607, 1988

２) Kaplan NM：The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med　149：1514-1520, 1989

３) DeFronzo RA, Ferrannini E：Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care　14：173-194, 1991

４) Matsuzawa Y, Funahashi T, Nakamura T：Molecular mechanism of metabolic syndrome X；contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci　892：146-154, 1999

５) Alberti KG, Zimmet PZ：Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1：diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med　15：539-553, 1998

６) Balkau B, Charles MA, Drivsholm T, et al：Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28：364-376, 2002

７) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults：Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA　285：2486-2497, 2001

８) メタボリックシンドローム診断基準検討委員会：メタボリックシンドロームの定義と診断基準．日内会誌　94：794-809，2005

９) The IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org/webdata/docs/IDF Metasyndrome definition.pdf［Accessed 07 Jun 2005］

10) Himsworth HP：Diabetes mellitus：its differentiation into insulin-sensitive and insulin-insensitive types. Lancet　1：127-130, 1936

11) Yalow RS, Berson SA：Immunoassay of endogenous plasma insulin in man. J Clin Invest　39：1157-1175, 1960

12) Rabinowitz D, Zierler KL：Forearmmetabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinisum. J Clin Invest　41：2173-2181, 1962

13) Yalow RS, Berson SA：Dinamics of insulin secretion in early diabetes in humans. Adv Metab Disord　1, (Suppl 1)：95＋, 1970

14) Matthews DR, Hosker JP, Rudenski AS, et al：Homeostasis model assessment：insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia　28：412-419, 1985

15) 日本糖尿病学会編：糖尿病治療ガイド，文光堂，p10，2004

16) Katz A, Nambi SS, Mather K, et al：Quantitative insulin sensitivity check index：a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab　85：2402-2410, 2000

17) Perseghin G, Caumo A, Caloni M, et al：Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in noobese individuals. J Clin Endocrinol Metab　86：4776-4781, 2001

18) Rabasa-Lhoret R, Bastard JP, Jan V, et al：Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab　88：4917-4923, 2003

19) DeFronzo RA, Tobin JD, Andres R：Glucose clamp technique：a method for quantifying insulin secretion and resistance. Am J Physiol　237：E214-223, 1979

20) Kawamori R, Morishima T, Ikeda M, et al：Effect of strict metabolic control on glucose handling by the liver and peripheral tissues in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract　23：155-161, 1994

21) Shen SW, Reaven GM, Farquhar JW：Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest　49：2151-2160, 1970

22) Harano Y, Ohgaku S, Hidaka H, et al：Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab　45：1124-1127, 1977

23) Ikebuchi M, Suzuki M, Kageyama A, et al：Modified method using a somatostatin analogue, octreotide acetate (Sandostatin(Ｒ)) to assess in vivo insulin sensitivity. Endocr J　43：125-130, 1996

24) Bonora E, Moghetti P, Zancanaro C, et al：Estimates of in vivo insulin action in man：Comparison of insulin tolerance tests with euglucemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab　68：374-378, 1989

25) Bergman RN, Ider YZ, Bowden CR, et al：Quantitative estimation of insulin sensitivity. Am J Physiol　236：E667-677, 1979

26) Pacini G, Bergman RN：MINMOD：a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequency sampled intravenous glucose tolerance test. Coput Methods Programs Biomed　23：113-122, 1986

27) Finegood DT, Hramiak IM, Dupre J：A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab　70：1538-1549, 1990

28) Beard JC, Bergman RN, Ward WK, et al：The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes　35：362-369, 1986

29) Tokuyama Y, Sakurai K, Yagui K, et al：Pathophysiologic phenotypes of Japanese subjects with varying degrees of glucose tolerance：using the combination of C-peptide secretion rate and minimal model analysis. Metabolism　50：812-818, 2001

30) Yoshida Y, Hashimoto N, Tokuyama Y, et al：Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis. Metabolism　53：1095-1100, 2004